Cargando…
Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma
Autores principales: | Mitra, Anupam, Luna, Jesus I, Marusina, Alina I, Merleev, Alexander, Kundu-Raychaudhuri, Smriti, Fiorentino, David, Raychaudhuri, Siba P, Maverakis, Emanual |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640976/ https://www.ncbi.nlm.nih.gov/pubmed/26134944 http://dx.doi.org/10.1038/jid.2015.252 |
Ejemplares similares
-
mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014) -
2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells
por: Le, Stephanie T., et al.
Publicado: (2019) -
Cross Talk between Neuroregulatory Molecule and Monocyte: Nerve Growth Factor Activates the Inflammasome
por: Datta-Mitra, Ananya, et al.
Publicado: (2015) -
Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019) -
Functional role of IL-22 in psoriatic arthritis
por: Mitra, Anupam, et al.
Publicado: (2012)